Physician profile
Jamal Aria
NPI 1376635698
$588.50
in general payments reported to CMS, 2019-2025
16 companies · $19.00 in 2025
The $19.00 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $31.67 · 2022: $48.74 · 2023: $30.47 · 2024: $62.64 · 2025: $19.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $97.67 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.50 | 2019 | |
| Incyte Corporation | $67.77 | 2022-2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.49 | 2019 | |
| Leo Pharma INC. | $42.53 | 2019 | |
| Almirall LLC | $37.64 | 2019-2025 | Klisyri |
| Mayne Pharma Commercial LLC | $35.08 | 2019 | |
| Sun Pharmaceutical Industries INC. | $30.65 | 2019-2023 | Absorica Ld, Winlevi |
| Dermavant Sciences, INC. | $26.95 | 2024 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $17.96 | 2019 | |
| Galderma Laboratories, L.P. | $16.98 | 2022 | |
| Epi Health, LLC | $16.24 | 2020 | |
| Journey Medical Corporation | $15.78 | 2022 | |
| Sandoz INC. | $15.43 | 2020 | |
| Promius Pharma LLC | $14.60 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Aria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.